{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T21:50:30Z","timestamp":1781905830946,"version":"3.54.5"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T00:00:00Z","timestamp":1608163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011272","name":"FP7 Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.pnpbp.2020.110226","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T04:32:24Z","timestamp":1608265944000},"page":"110226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Activation and deactivation steps in the tryptophan breakdown pathway in major depressive disorder: A link to the monocyte inflammatory state of patients"],"prefix":"10.1016","volume":"107","author":[{"given":"Gara","family":"Arteaga-Henriquez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianka","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Weidinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Grosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Moll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Schuetze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Wijkhuijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gommaar","family":"Op de Beeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raf","family":"Berghmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan A.","family":"Versnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Arolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemmo A.","family":"Drexhage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2020.110226_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Washington, DC","author":"American Psychiatric Association","year":"2000"},{"issue":"5","key":"10.1016\/j.pnpbp.2020.110226_bb0010","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0889-1591(02)00009-0","article-title":"Anhedonic and anxiogenic effects of cytokine exposure. Cytokines, stress and depressive illness","volume":"16","author":"Anisman","year":"2002","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0015","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.neubiorev.2018.05.031","article-title":"Role of the kynurenine pathway and its metabolites in mood disorders: a systematic review and meta-analysis of clinical studies","volume":"92","author":"Arnone","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0020","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fpsyt.2019.00458","article-title":"Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-MOODINFLAME consortium","volume":"10","author":"Arteaga-Henr\u00edquez","year":"2019","journal-title":"Front. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2020.110226_bb0025","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1177\/0269881113499209","article-title":"Tryptophan: the key to boosting brain serotonin synthesis in depressive illness","volume":"27","author":"Badawy","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13098-015-0113-5","article-title":"Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D","volume":"8","author":"Baldeon-Rojas","year":"2016","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0035","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.3968","article-title":"Revisiting the tryptophan-serotonin deficiency and the inflammatory hypotheses of major depression in a biopsychosocial approach","volume":"5","author":"Baranyi","year":"2017","journal-title":"PeerJ"},{"issue":"12","key":"10.1016\/j.pnpbp.2020.110226_bb0040","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","article-title":"Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u201creal-time\u201d quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR): a Europe Against Cancer Program","volume":"17","author":"Beillard","year":"2003","journal-title":"Leukemia"},{"issue":"2\u20133","key":"10.1016\/j.pnpbp.2020.110226_bb0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.psychres.2015.03.031","article-title":"The role of the kynurenine pathway in suicidality in adolescent major depressive disorder","volume":"227","author":"Bradley","year":"2015","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.pnpbp.2020.110226_bb0055","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/annrheumdis-2012-201381","article-title":"Prevalence of interferon type I signature in CD14 monocytes of patients with Sj\u00f6gren\u2019s syndrome and association with disease activity and BAFF gene expression","volume":"72","author":"Brkic","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"Pt B","key":"10.1016\/j.pnpbp.2020.110226_bb0060","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neuropharm.2016.01.034","article-title":"Kynurenine pathway metabolites in suicidality","volume":"112","author":"Bryleva","year":"2017","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pnpbp.2020.110226_bb0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00406-014-0562-0","article-title":"Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses?","volume":"265","author":"Busse","year":"2015","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"10","key":"10.1016\/j.pnpbp.2020.110226_bb0070","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archgenpsychiatry.2011.2094","article-title":"Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration","volume":"69","author":"Capuron","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.110226_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.118","article-title":"Inflammatory activation is associated with a reduced glucocorticoid receptor alpha\/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder","volume":"4","author":"Carvalho","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"Suppl. 14","key":"10.1016\/j.pnpbp.2020.110226_bb0080","first-page":"11","article-title":"Monoamine dysfunction and the pathophysiology and treatment of depression","volume":"59","author":"Charney","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2020.110226_bb0085","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1503\/jpn.150226","article-title":"Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals","volume":"41","author":"Clark","year":"2016","journal-title":"J. Psychiatry Neurosci."},{"issue":"S7","key":"10.1016\/j.pnpbp.2020.110226_bb0090","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.5694\/j.1326-5377.2009.tb02471.x","article-title":"Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence","volume":"190","author":"Clarke","year":"2009","journal-title":"Med. J. Aust."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.110226_bb0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/pcn.12944","article-title":"Peripheral tryptophan, serotonin, kynurenine, and their metabolites in major depression: a case-control study","volume":"74","author":"Colle","year":"2020","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"7","key":"10.1016\/j.pnpbp.2020.110226_bb0100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0024-3205(97)00990-9","article-title":"Depression, stress and immunological activation: the role of cytokines in depressive disorders","volume":"62","author":"Connor","year":"1998","journal-title":"Life Sci."},{"issue":"Suppl","key":"10.1016\/j.pnpbp.2020.110226_bb0105","first-page":"4","article-title":"Serotonin and its place in the pathogenesis of depression","volume":"49","author":"Coopen","year":"1988","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2020.110226_bb0110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.tips.2008.05.004","article-title":"Serotonin and depression: pathophysiological mechanism or marketing myth?","volume":"29","author":"Cowen","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.110226_bb0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/wps.20229","article-title":"What has serotonin to do with depression?","volume":"14","author":"Cowen","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.110226_bb0125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.schres.2019.02.020","article-title":"Serum xanthurenic acid levels: reduced in subjects at ultra high risk for psychosis","volume":"208","author":"Curto","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s10194-016-0638-5","article-title":"Altered kynurenine pathway metabolites in serum of chronic migraine patients","volume":"17","author":"Curto","year":"2015","journal-title":"J. Headache Pain"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.110226_bb0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.110226_bb0135","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","article-title":"Inflammation-associated depression: from serotonin to kynurenine","volume":"36","author":"Dantzer","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2020.110226_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.psyneuen.2018.05.019","article-title":"Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes","volume":"95","author":"Doolin","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"10","key":"10.1016\/j.pnpbp.2020.110226_bb0141","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1017\/S1461145710000799","article-title":"Inflammatory gene expression in monocytes of patients with schizophrenia: overlap and difference with bipolar disorder. A study in naturalistic treated patients","volume":"13","author":"Drexhage","year":"2010","journal-title":"Int .J. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2020.110226_bb0150","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/npp.2012.248","article-title":"Connecting inflammation with glutamate agonism in suicidality","volume":"38","author":"Erhardt","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2020.110226_bb0155","doi-asserted-by":"crossref","first-page":"17799","DOI":"10.1038\/srep17799","article-title":"Xanthurenic acid activates mGlu2\/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia","volume":"5","author":"Fazio","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.110226_bb0160","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0091-3057(02)00843-2","article-title":"The selective group mGlu2\/3 receptor agonist LY379268 suppresses REM sleep and fast EEG in the rat","volume":"73","author":"Feinberg","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1192\/bjp.175.3.205","article-title":"Classification in psychiatry: ICD-10 v. DSM-IV. A response","volume":"175","author":"First","year":"1999","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.110226_bb0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3389\/fnbeh.2018.00127","article-title":"A comprehensive overview on stress neurobiology: basic concepts and clinical implications","volume":"12","author":"Godoy","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0175","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2014.08.004","article-title":"Clinical characteristics of inflammation-associated depression: monocyte gene expression is age-related in major depressive disorder","volume":"44","author":"Grosse","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0180","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bbi.2015.12.003","article-title":"Deficiencies of the T and natural killer cell system in major depressive disorder: T regulatory cell defects are associated with inflammatory monocyte activation","volume":"54","author":"Grosse","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.110226_bb0185","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.110226_bb0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","article-title":"Monoamine neurocircuitry in depression and strategies for new treatments","volume":"45","author":"Hamon","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.pnpbp.2020.110226_bb0195","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.bbi.2012.05.010","article-title":"Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation","volume":"26","author":"Hughes","year":"2012","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.pnpbp.2020.110226_bb0200","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbi.2007.01.010","article-title":"Depressive disorders and immunity: 20 years of progress and discovery","volume":"21","author":"Irwin","year":"2007","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0205","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jad.2018.01.014","article-title":"Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-na\u00efve patients with major depressive disorder: an exploratory pilot case-control study","volume":"231","author":"Kuwano","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"7586","key":"10.1016\/j.pnpbp.2020.110226_bb0210","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(69)91140-4","article-title":"Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect","volume":"1","author":"Lapin","year":"1969","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.110226_bb0215","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.neubiorev.2011.12.005","article-title":"Mechanistic explanations of how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression","volume":"36","author":"Leonard","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.110226_bb0220","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biopsych.2009.01.030","article-title":"Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempers and related to symptom severity","volume":"66","author":"Lindqvist","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.110226_bb0225","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0447.1990.tb06443.x","article-title":"Suppressant effects of dexamethasone on the availability of plasma L-tryptophan and tyrosine in healthy controls and in depressed patients","volume":"81","author":"Maes","year":"1990","journal-title":"Acta Psychiatr. Scand."},{"issue":"3","key":"10.1016\/j.pnpbp.2020.110226_bb0230","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2020.110226_bb0235","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39629","article-title":"Association of increased Treg cell levels with elevated Indoleamine-2,3-dioxygenase activity and an imbalanced kynurenine pathway in interferon-positive primary Sj\u00f6gren\u2019s syndrome","volume":"68","author":"Maria","year":"2016","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.pnpbp.2020.110226_bb0240","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/sj.mp.4002005","article-title":"Group II metabotropic glutamate receptor ligands as adjunctive drugs in the treatment of depression: a new strategy to shorten the latency of antidepressant medication?","volume":"12","author":"Matrisciano","year":"2007","journal-title":"Mol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.110226_bb0245","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000446370","article-title":"Exaggerated increases in microglia proliferation, brain inflammatory response and sickness behavior upon lipopolysaccharide stimulation in non-obese diabetic mice","volume":"23","author":"McGuiness","year":"2016","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.pnpbp.2020.110226_bb0250","series-title":"Neurokynurenines-SEIZURES or\/and Anxiety in Children With Epilepsy?","author":"Melnikova","year":"2003"},{"issue":"9","key":"10.1016\/j.pnpbp.2020.110226_bb0255","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1080\/15622975.2018.1468031","article-title":"Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide","volume":"20","author":"Messaoud","year":"2019","journal-title":"World J. Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.110226_bb0260","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0924-977X(01)00081-5","article-title":"Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis","volume":"11","author":"Mikova","year":"2001","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2020.110226_bb0265","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0278-5846(93)90055-W","article-title":"Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis","volume":"17","author":"M\u00fcller","year":"1993","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"5\u20136","key":"10.1016\/j.pnpbp.2020.110226_bb0270","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0306-9877(03)00207-X","article-title":"Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression","volume":"61","author":"Myint","year":"2003","journal-title":"Med. Hypotheses"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.110226_bb0275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jad.2005.07.008","article-title":"Th1, Th2, and Th3 cytokine alterations in major depression","volume":"88","author":"Myint","year":"2005","journal-title":"J. Affect. Disord."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2020.110226_bb0280","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0285","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1744-9081-6-32","article-title":"Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention","volume":"6","author":"Oades","year":"2010","journal-title":"Behav. Brain Funct."},{"issue":"Pt B","key":"10.1016\/j.pnpbp.2020.110226_bb0290","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.neuropharm.2015.12.004","article-title":"Stress-related regulation of the kynureine pathway: relevance to neuropsychiatric and degenerative disorders","volume":"112","author":"O\u2019Farrell","year":"2017","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.pnpbp.2020.110226_bb0295","doi-asserted-by":"crossref","first-page":"e906","DOI":"10.4088\/JCP.13r08908","article-title":"Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis","volume":"75","author":"Ogawa","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"4","key":"10.1016\/j.pnpbp.2020.110226_bb0305","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s40473-015-0050-5","article-title":"Novel glutamatergic treatments for severe mood disorders","volume":"2","author":"Park","year":"2015","journal-title":"Curr. Behav. Neurosci. Rep."},{"issue":"11","key":"10.1016\/j.pnpbp.2020.110226_bb0310","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/obr.12052","article-title":"A systematic review of variables associated with the relationship between obesity and depression","volume":"14","author":"Preiss","year":"2013","journal-title":"Obes. Rev."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.110226_bb0315","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s11011-018-0290-7","article-title":"IDO and TDO as potential therapeutic target in different types of depression","volume":"33","author":"Qin","year":"2018","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0320","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.psyneuen.2014.03.013","article-title":"Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms?","volume":"45","author":"Quak","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"10.1016\/j.pnpbp.2020.110226_bb0325","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.110226_bb0330","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0165-1781(86)90060-0","article-title":"The Inventory for Depressive Symptomatology (IDS): preliminary findings","volume":"18","author":"Rush","year":"1986","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0335","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2019.10.005","article-title":"Tryptophan metabolite concentrations in depressed patients before and after electroconfulsive therapy","volume":"83","author":"Ryan","year":"2020","journal-title":"Brain Behav. Immun."},{"issue":"2","key":"10.1016\/j.pnpbp.2020.110226_bb0340","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/npp.2014.194","article-title":"Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder","volume":"40","author":"Savitz","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2020.110226_bb0345","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S2215-0366(14)70336-0","article-title":"WHO launches the first world suicide report","volume":"1","author":"Saxena","year":"2014","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2020.110226_bb0350","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41398-020-00979-z","article-title":"Childhood trauma, suicide risk and inflammatory phenotypes of depression: insights from monocyte gene expression","volume":"10","author":"Schiweck","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"Pt B","key":"10.1016\/j.pnpbp.2020.110226_bb0355","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"},{"issue":"Suppl. 20","key":"10.1016\/j.pnpbp.2020.110226_bb0360","first-page":"22","article-title":"1998. The mini-international neuropsychiatric interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"7526","key":"10.1016\/j.pnpbp.2020.110226_bb0365","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/515180a","article-title":"Mental health: a world of depression","volume":"515","author":"Smith","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.pnpbp.2020.110226_bb0370","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2012.09.006","article-title":"An expanding range of targets for kynurenine metabolites of tryptophan","volume":"34","author":"Stone","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.110226_bb0375","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bbi.2011.05.002","article-title":"Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder","volume":"26","author":"Sublette","year":"2011","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.pnpbp.2020.110226_bb0380","first-page":"46","article-title":"The biology of tryptophan depletion and mood disorders","volume":"47","author":"Toker","year":"2010","journal-title":"Isr. J. Psychiatr. Relat. Sci."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0385","doi-asserted-by":"crossref","first-page":"73.82","DOI":"10.1017\/S0033291703001107","volume":"34","author":"Trivedi","year":"2004","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0390","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fpsyt.2017.00034","article-title":"T cell deficits and overexpression of hepatocyte growth factor in anti-inflammatory circulating monocytes of middle-aged patients with bipolar disorder characterized by a high prevalence of metabolic syndrome","volume":"8","author":"Vogels","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.110226_bb0395","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.02.021","article-title":"Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: a systematic review and meta-analysis","volume":"79","author":"Wang","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"6","key":"10.1016\/j.pnpbp.2020.110226_bb0400","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.bbi.2011.03.006","article-title":"TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3, and PU-1 as important transcription factors","volume":"25","author":"Weigelt","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0405","author":"WHO"},{"issue":"5","key":"10.1016\/j.pnpbp.2020.110226_bb0410","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.88","article-title":"Serum kynurenic acid is reduced in affective psychosis","volume":"7","author":"Wurfel","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2020.110226_bb0300","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","article-title":"Kynurenine pathway in depression: a systematic review and meta-analysis","volume":"90","author":"Ogyu","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2020.110226_bb0145","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.bbi.2019.01.007","article-title":"Editorial: activation and deactivation of inflammatory pathways. The disequilibrium of immune-neuro-endocrine networks in psychiatric disorders","volume":"78","author":"Drexhage","year":"2019","journal-title":"Brain Behav. Immun."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462030542X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462030542X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:52:49Z","timestamp":1759521169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858462030542X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":82,"alternative-id":["S027858462030542X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110226","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation and deactivation steps in the tryptophan breakdown pathway in major depressive disorder: A link to the monocyte inflammatory state of patients","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110226","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110226"}}